Vehicle Safety Product Safety Food Safety Pet Safety Drug Safety Device Safety Workplace Safety Bridge Safety Aviation Safety Dam Safety Nursing Homes Water Safety Railroad Safety Pipeline Safety Environmental

Cefepime for Injection, USP 2 grams per vial, Rx only, Mfd. for Meitheal Pharmaceuticals Chicago,...

FDA Recall #D-0606-2023 — Class II — May 15, 2023

Recall #D-0606-2023 Date: May 15, 2023 Classification: Class II Status: Terminated

Product Description

Cefepime for Injection, USP 2 grams per vial, Rx only, Mfd. for Meitheal Pharmaceuticals Chicago, IL 60631, NDC 71288-009-20

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

Astral SteriTech Private Ltd. — Vadodara, N/A

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

107,320 vials

Distribution

Nationwide within the United States

Code Information

All lots within expiry.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

Back to All Drug Recalls